Lung neoplasm

Celgene

Company1 trialPhase 4143 people

Sanofi

Company3 trialsPhase 3549 people

Merck & Co.

Company1 trialPhase 3870 people

Jiangsu HengRui Medicine

Company1 trialPhase 3419 people

Roche

Company1 trialPhase 3223 people

Eli Lilly and Company

Company3 trialsPhase 241 people

Amgen

Company1 trialPhase 263 people

Pfizer

Company1 trialPhase 240 people